期刊文献+

阴道镜下四象限活检在宫颈癌前病变筛查中的价值 被引量:25

Value of 4-quadrant biopsies under colposcopy for detecting precancerous lesions in cervical cancer screening
原文传递
导出
摘要 目的评价阴道镜下四象限活检在宫颈癌前病变筛查中的价值。方法利用1999年山西省襄垣县开展的1997例妇女的宫颈癌筛查横断面研究数据,比较阴道镜诊断宫颈高度鳞状上皮及以上病变(HSIL+)的敏感度、特异度和准确率等,同时比较阴道镜下四象限点活检与阴道镜下可疑病变活检病理结果。结果1997例筛查者中,病理诊断阴性1784例(89.3%),低度鳞状上皮内病变(LSIL)127例(6.4%),HSIL74例(3.7%),鳞状细胞癌(SCC)12例(0.6%)。阴道镜检查为阴性1478例(74.O%);阴道镜检查为阳性519例(26.0%),其中LSIL463例(23.2%),HSIL41例(2.1%),可疑癌15例(0.8%)。阴道镜检查的阳性率为26.0%(519/1997),与病理诊断结果的一致率为73.8%。以病理诊断为金标准,阴道镜检查发现HSIL+的敏感度为81.4%,特异度为76.5%。88例人乳头瘤病毒(HPV)阳性、液基细胞学(LBC)诊断未明确意义的非典型鳞状上皮细胞(ASC—US)及以上病变、阴道镜阴性患者中,病理诊断HSIL14例(15.9%),LSIL29例(33.0%);116例HPV阳性、LBC正常、阴道镜阴性患者中,病理诊断HSIL2例(1.7%),LSIL6例(5.2%)。两组患者的HSIL和LSIL检出率差异均有统计学意义(均P〈0.001)。阴道镜阴性的筛查者中,四象限活检对HSIL和LSIL病变的检出率分别为1.1%和4.7%。阴道镜检查结果异常519例,阴道镜下可疑病变活检与四象限活检诊断结果不一致19例,一致500例,符合率为96.3%。与四象限活检比较,若仅以阴道镜下异常象限进行指示性活检,则漏诊14.8%(19/128)的宫颈病变,其中漏诊8.6%(5/58)的HSIL,漏诊24.1%(14/58)的LSIL。结论阴道镜下四象限活检能发现更多的宫颈病变,准确性高。作为宫颈癌前病变筛查的重要手段,阴道镜下四象限活检可提高宫颈癌前病变的检出率。 Objective To evaluate the value of colposcopical 4-quadrant biopsies for detecting precancerous lesion in cervical cancer screening. Methods We used the data of a cross-sectional screening study in 1999, in which 1 997 women received cervical cancer screening in Xiang Yuan County, Shanxi province. The sensitivity, specificity and accuracy of both 4-quadrant biopsy and eolposeopy directed biopsy to detect high-grade or more severe squamous intraepithelial lesions (HSIL^+) were calculated. Results 1 784(89. 3%) women who received 4-quadrant biopsies and endocervical curettage were negative. 127 (6.4%) women were diagnosed as LSIL, 74(3.7%) women as HSIL and 12(0.6%) cases of squamous cell carcinoma. 1 478(74. 0%) women who received biopsies in the sites of abnormal lesions were negative, 463 (23.2%) cases of LSIL, 41(2.1%) cases of HSIL, 15(0.8%) cases of squamous cell carcinoma. The positive rate was 26.0% (519/1 997) for colposcopy, and the coincidence rate was 73.7% with pathological diagnosis. Sensitivity and specificity were 81.4% and 76.5% of colposcopy for HSIL^+. In total of 519 women were found to be with any abnormal colposcopic appearance. The consistency rate between 4-quadrant biopsies and suspicious lesion- directed biopsies was 96.3%. By suspicious lesion-directed biopsy alone, 14.8% cervical lesions were missdiagnosed, of which 8.6%(5/58) cases of total HSIL and 24.1% (14/58) cases of all LSIL. Conclusions 4- quadrant biopsy can detect more HSIL^+ lesions and is more accurate than suspicious lesion biopsy alone. As an important triage technique to detect cervical precancerous lesions, it can improve the detection rate of HSIL^+ lesions in cervical cancer screening.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2015年第11期875-879,共5页 Chinese Journal of Oncology
关键词 宫颈疾病 宫颈肿瘤 阴道镜检查 普查 诊断 Uterine cervical diseases Uterine cervical neoplasms Colposcopy Mass screening Diagnosis
  • 相关文献

参考文献16

二级参考文献54

  • 1李洁,刘宝印,zur Hausen H,王宏,杨学志,李力,刘文,刘洪隐,陆克昭,刘旭,牛春燕,裴润芳,苏钟浦,王言贵,董继华,张桂宁,刘春杰,许吉林,林毓纯.中国妇女宫颈癌组织中人乳头瘤病毒感染及其地理分布的调查[J].中华实验和临床病毒学杂志,1996,10(1):50-55. 被引量:67
  • 2Wu EQ, Zhang GN, Yu XH, et al. Evaluation of high-risk human papillomaviruses type distribution in cervical cancer in Sichuan province of China [ J ]. BMC Cancer, 2008, 8 : 202.
  • 3Lo KW, Wong YF, Chan MK, et al. Prevalence of human papillomavirus in cervical cancer: A multicenter study in China [J]. Int J Cancer, 2002, 100 (3):327.
  • 4Liu SS, Tsang PC, Chan KY, et al. Distribution of six oncogenic types of human papillomavirus and type 16 integration analysis in Chinese women with cervical precancerous lesions and carcinomas [J]. Tumour Siol, 2008, 29 (2) : 105.
  • 5Chen W, Zhang X, Molijn A, et al. Human papillomavirus type-distribution in cervical cancer in China: The importance of HPV 16 and 18 [J]. Cancer Causes Control, 2009, 20 (9):1705.
  • 6Schiller JT, Castellsague X, Villa LL, et al. An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results [J]. Vaccine, 2008, 26 ( Suppl 10) : K53.
  • 7Agorastos T, Chatzigeorgiou K, Brotherton JM, et al. Safety of human papillomavirus (HPV) vaccines : A review of the international experience so far [J]. Vaccine, 2009, 27 (52) : 7270.
  • 8WHO. Human papillomavirus vaccines: WHO position palaer [J]. Biological. 2009, 37 (5):338.
  • 9Zhao FH, Zhao N, Zhang LQ, et al. Age of sexual debut among Chinese women: Suggestions for optimal age of HPV vaccination in China. 26th International Papillomavirus Conference and Clinical Workshop, Palais Des Congres De Montreal, Canada 2010.
  • 10Li J, Li LK, Ma JF, et al. Knowledge and attitudes about human papillomavirus (HPV) and HPV vaccines among women living in metropolitan and rural regions of China [J]. Vaccine, 2009, 27 (8):1210.

共引文献520

同被引文献179

引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部